Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

被引:132
作者
Cintolo-Gonzalez, Jessica A. [1 ]
Braun, Danielle [2 ,3 ]
Blackford, Amanda L. [4 ]
Mazzola, Emanuele [3 ]
Acar, Ahmet [1 ]
Plichta, Jennifer K. [5 ]
Griffin, Molly [1 ]
Hughes, Kevin S. [1 ]
机构
[1] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA
[2] Harvard Univ TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA
[3] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[4] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[5] Duke Univ Hlth Syst, Durham, NC USA
关键词
Risk assessment; Risk Models; Breast Cancer Screening; MANCHESTER SCORING SYSTEM; OVARIAN-CANCER; PREDICTION MODEL; FAMILY-HISTORY; BRCA2; MUTATION; CARRIER PROBABILITIES; TYRER-CUZICK; GAIL MODEL; GENETIC SUSCEPTIBILITY; GERMLINE MUTATIONS;
D O I
10.1007/s10549-017-4247-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Numerous models have been developed to quantify the combined effect of various risk factors to predict either risk of developing breast cancer, risk of carrying a high-risk germline genetic mutation, specifically in the BRCA1 and BRCA2 genes, or the risk of both. These breast cancer risk models can be separated into those that utilize mainly hormonal and environmental factors and those that focus more on hereditary risk. Given the wide range of models from which to choose, understanding what each model predicts, the populations for which each is best suited to provide risk estimations, the current validation and comparative studies that have been performed for each model, and how to apply them practically is important for clinicians and researchers seeking to utilize risk models in their practice. This review provides a comprehensive guide for those seeking to understand and apply breast cancer risk models by summarizing the majority of existing breast cancer risk prediction models including the risk factors they incorporate, the basic methodology in their development, the information each provides, their strengths and limitations, relevant validation studies, and how to access each for clinical or investigative purposes.
引用
收藏
页码:263 / 284
页数:22
相关论文
共 109 条
[1]  
Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x
[2]   Breast Cancer Risk Assessments Comparing Gail and CARE Models in African-American Women [J].
Adams-Campbell, Lucile L. ;
Makambi, Kepher H. ;
Frederick, Wayne A. I. ;
Gaskins, Melvin ;
DeWitty, Robert L. ;
McCaskill-Stevens, Worta .
BREAST JOURNAL, 2009, 15 :S72-S75
[3]   Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme [J].
Amir, E ;
Evans, DG ;
Shenton, A ;
Lalloo, F ;
Moran, A ;
Boggis, C ;
Wilson, M ;
Howell, A .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (11) :807-814
[4]   Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models [J].
Amir, Eitan ;
Freedman, Orit C. ;
Seruga, Bostjan ;
Evans, D. Gareth .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) :680-691
[5]  
Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
[6]   Risk prediction models of breast cancer: a systematic review of model performances [J].
Anothaisintawee, Thunyarat ;
Teerawattananon, Yot ;
Wiratkapun, Chollathip ;
Kasamesup, Vijj ;
Thakkinstian, Ammarin .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (01) :1-10
[7]   Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation:: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics [J].
Antoniou, A. C. ;
Hardy, R. ;
Walker, L. ;
Evans, D. G. ;
Shenton, A. ;
Eeles, R. ;
Shanley, S. ;
Pichert, G. ;
Izatt, L. ;
Rose, S. ;
Douglas, F. ;
Eccles, D. ;
Morrison, P. J. ;
Scott, J. ;
Zimmern, R. L. ;
Easton, D. F. ;
Pharoah, P. D. P. .
JOURNAL OF MEDICAL GENETICS, 2008, 45 (07) :425-431
[8]   The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions [J].
Antoniou, A. C. ;
Cunningham, A. P. ;
Peto, J. ;
Evans, D. G. ;
Lalloo, F. ;
Narod, S. A. ;
Risch, H. A. ;
Eyfjord, J. E. ;
Hopper, J. L. ;
Southey, M. C. ;
Olsson, H. ;
Johannsson, O. ;
Borg, A. ;
Passini, B. ;
Radice, P. ;
Manoukian, S. ;
Eccles, D. M. ;
Tang, N. ;
Olah, E. ;
Anton-Culver, H. ;
Warner, E. ;
Lubinski, J. ;
Gronwald, J. ;
Gorski, B. ;
Tryggvadottir, L. ;
Syrjakoski, K. ;
Kallioniemi, O-P ;
Eerola, H. ;
Nevanlinna, H. ;
Pharoah, P. D. P. ;
Easton, D. F. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1457-1466
[9]   A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes [J].
Antoniou, AC ;
Pharoah, PDP ;
McMullan, G ;
Day, NE ;
Stratton, MR ;
Peto, J ;
Ponder, BJ ;
Easton, DF .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :76-83
[10]   BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families [J].
Antoniou, AC ;
Durocher, F ;
Smith, P ;
Simard, J ;
Easton, DF .
BREAST CANCER RESEARCH, 2006, 8 (01)